Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma

Journal of Asthma

Volumn 45, Issue 5, 2008, Pages 397-401

  Bruno, Sposato ^a   Antonio, Calabrese ^a   Roberta, Barzan ^a   Clemente, Franco ^a  

^a MISERICORDIA HOSPITAL   (Italy)

Author keywords

Anticholinergic; Asthma; Bronchodilator; Methacholine test; Protective effect

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; METHACHOLINE; OXITROPIUM BROMIDE; TIOTROPIUM BROMIDE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE;

ADMINISTRATION, INHALATION; ADULT; ANALYSIS OF VARIANCE; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; MALE; METHACHOLINE CHLORIDE; PREMEDICATION; PROBABILITY; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SCOPOLAMINE DERIVATIVES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 45849107672     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900801971818     Document Type: Article

References (27)

1. Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol 2006; 533:36-39.
2. Barnes PJ. Neural control of human airways in health and disease. Am Rev Respir Dis 1986; 134:1289-1314.
3. Chapman KR. The role of anticholinergic bronchodilators in adult asthma and COPD. Lung 1990; 168:295-303.
4. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report, 2005. www.goldcopd.com
5. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997. NIH Publication 97-4051.
6. Rodrigo GJ, Rodrigo C. The role of Anticholinergics in acute asthma treatment. Chest 2002; 121:1977-1987.
7. Quezada A, Mallol J, Moreno J, Rodriguez J. Effect of different inhaled bronchodilators on recovery from methacholine-induced bronchoconstriction in asthmatic children. Pediatr Pulmonol 1999; 28:125-129.
8. Gross NJ, Skorodin MS. Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 1984; 129:856-870.
9. Magnussen H, Nowak D, Wiebicke W. Effect of inhaled ipratropium bromide on the airway response to methacholine, histamine and exercise in patients with mild bronchial asthma. Respiration 1992; 59:42-47.
10. Crimi N, Palermo F, Olivieri R, Polosa R, Settinieri I, Mistretta A. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Eur Respir J 1992; 5:560-565.
11. Sposato B, Mariotta S, Ricci A, Bruno P, Terzano C, Mannino F. The influence of Ipratropium Bromide in the recovery phase of methacholine induced-bronchospasm. Eur Rev Med Pharmacol Sci 2005; 9117-123.
12. Wilson NM, Green S, Coe C, Barnes PJ. Duration of protection by oxitropium bromide against cholinergic challenge. Eur J Respir Dis 1987; 71:455-458.
13. O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154:876-880.
14. Terzano C, Petroianni A, Ricci A, D'Antoni L, Allegra L. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness. Eur Rev Med Pharmacol Sci 2004; 8:259-264.
15. Barnes PJ, Belvisi MG, Mak JC, Haddad EB, O'Connor B. Tiotropium bromide (Ba 679 Br), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci 1995; 56:853-859.
16. Maesen FPV, Smeets JJ, Sledsens TJH, Wald FDM, Cornelissen PJG. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1506-1513.
17. Frith PA, Jenner B, Dangerfield R, Atkinson J, Drennan C. Oxitropium bromide: dose-response and time-response study on a new anticholinergic bronchodilator drug. Chest 1986; 89:249-253.
18. Pounsford JC, Fuller RW, Saunders KB. A cumulative dose-response study of oxitropium bromide (Ba 253) in asthmatics. Eur J Respir Dis 1983; (Suppl 128):536-539.
19. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo JL. Airway responsiveness. Standardized challenge testing with parmacological, physical and sensitizing stimuli in adults. Eur Resp J 1993; 6 (suppl)16:53-83.
20. American Thoracic Society. Guidelines for Methacholine and Exercise Challenge Testing-1999. Am J Respir Crit Care Med 2000; 161:309-329.
21. O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S. Analysis of dose-response curves to methacholine. Am Rev Respir Dis 1987; 136:1412-1417.
22. Reid JK, Davis BE, Cockcroft DW. The effect of Ipratropium nasal spray on bronchial methacholine challenge. Chest 2005; 128:1245-1247.
23. Disse B, Reichal R, Speck G, Travnecker W, Rominger L, Hammer R. Ba679BR, a novel anticholinergic bronchodilator: preclinical and clinical aspects. Life Sci 1993; 52:537-544.
24. 3H] BA 679. A slow-dissociating muscarinic receptor antagonist in human lung: radioligand binding and autoradiographic mapping. Mol Pharmacol 1994; 45:899-907.
25. Peel ET, Anderson G, Cheong B, Broderick N. A comparison of oxitropium bromide and ipratropium bromide in asthma. Eur J Respir Dis 1984; 66:665-673.
26. Lulling J, Delwiche JP, Prignot J. Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide. Respiration 1981; 42:188-192.
27. Gross NJ, Petty TL, Friedman M, Skorodin MS, Silvers GW, Donohue JF. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis 1989; 139:1188-1191